Ranking
Recommendations expose evidence, impact, confidence, effort, cost, risk and uncertainty.
Firequark software
Growth Cockpit.
Explainable next-action ranking.
Prioritize work with evidence, impact, confidence, effort, cost, risk and uncertainty visible together.
Growth Cockpit status
- Current Track A software is technically complete and deployed as a controlled beta on the shared-host profile.
- The shared-host beta is explicitly non-production-grade; external reads and writes remain off by default.
- Synthetic and fictional records demonstrate software behavior, not customer results or market validation.
Explainable next-action ranking
Prioritize work with evidence, impact, confidence, effort, cost, risk and uncertainty visible together.
Growth Cockpit is part of Firequark Growth OS rather than a disconnected marketing service. Its workflows preserve review, tenant scope and evidence boundaries.
Capabilities
Inside Growth Cockpit.
Decisions
Snooze and reopen are reversible; permanent suppression records a reason.
Attribution
Funnel and outcome views remain explicit about gaps and do not invent causal revenue.
Deployment profiles
One product contract,
two operating profiles.
| Profile | Use | Current boundary |
|---|---|---|
| DreamHost shared MVP | Internal use and authorized controlled beta | Static app, PHP API, SQLite, bounded cron; non-production-grade |
| Production profile | Future higher-scale operation | Next server, API, workers, PostgreSQL RLS, Redis and private objects; not publicly launched |
What remains external
Technical completion
is not market proof.
Real-user validation
Fixtures cannot satisfy paid activation, retention or customer-outcome gates.
Provider launch
Live messaging, publishing, ads, billing and other consequential providers require separate credentials and approval.
Production operation
Monitoring ownership, support, legal review, backups and production infrastructure remain launch decisions.
Ignition
Evaluate Growth Cockpit with a guided proof-of-value.
The fixed-scope starting product is a 30-day controlled-beta evaluation with explicit boundaries and no invented result claims.